We are live on
!
Find out more
SAM
Sectoral Asset Management Portfolio holdings
AUM
$121M
1-Year Est. Return
73.47%
This Fund
S&P 500
This Quarter
Est. Return
-8.43%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$514M
AUM Growth
-$86.2M
(-14%)
Cap. Flow
-$11.8M
Cap. Flow
% of AUM
-2.3%
Top 10 Holdings %
Top 10 Hldgs %
22.06%
Holding
136
New
15
Increased
60
Reduced
35
Closed
13
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CONMED
CNMD
|
+$7.87M |
| 2 |
GoodRx Holdings
GDRX
|
+$6.71M |
| 3 |
Iovance Biotherapeutics
IOVA
|
+$6.43M |
| 4 |
Acadia Pharmaceuticals
ACAD
|
+$5.7M |
| 5 |
Insulet
PODD
|
+$5.42M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Treace Medical Concepts
TMCI
|
+$9.71M |
| 2 |
Inspire Medical Systems
INSP
|
+$7.79M |
| 3 |
AGTI
Agiliti Inc
AGTI
|
+$7.74M |
| 4 |
Travere Therapeutics
TVTX
|
+$6.69M |
| 5 |
Amylyx Pharmaceuticals
AMLX
|
+$6.63M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 97.41% |
| 2 | Industrials | 2.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
126
Inspire Medical Systems
INSP
$1.81B
| – | – |
-24,000
| Closed | -$7.79M |
|
|
SLRN
127
DELISTED
ACELYRIN
SLRN
| – | – |
-201,017
| Closed | -$4.2M |
|
|
128
Treace Medical Concepts
TMCI
$305M
| – | – |
-379,443
| Closed | -$9.71M |
|
129
Tempest Therapeutics
TPST
$14.3M
| – | – |
-16,876
| Closed | -$279K |
|
|
TSVT
130
DELISTED
2seventy bio
TSVT
| – | – |
-462,485
| Closed | -$4.68M |
|
|
131
Travere Therapeutics
TVTX
$5.11B
| – | – |
-435,313
| Closed | -$6.69M |
|
|
SILK
132
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| – | – |
-80,500
| Closed | -$2.62M |
|
|
GRTX
133
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
| – | – |
-2,005,054
| Closed | -$6.26M |
|
|
AGTI
134
DELISTED
Agiliti Inc
AGTI
| – | – |
-469,277
| Closed | -$7.74M |
|
|
EQRX
135
DELISTED
EQRx, Inc. Common Stock
EQRX
| – | – |
-1,135,967
| Closed | -$2.11M |
|
|
RETA
136
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| – | – |
-47,500
| Closed | -$4.84M |
|
Similar funds
RIP
LFWA
CF
WIM
MW
AFC
TGM
BIS
Sectoral Asset Management's Q3 2023 Portfolio in Review
As of Q3 2023, Sectoral Asset Management held 136 positions worth $514M, down 14% from $600M the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Sectoral Asset Management's Q3 2023 filing shows 15 new, 60 increased, 35 reduced and 13 closed positions. Its largest new stake was GoodRx Holdings: 1,007,000 shares worth $5.67M. The largest sale was Treace Medical Concepts, an estimated $9.71M.
By sector, the portfolio is most concentrated in Healthcare at 97% of assets, up from 96% a quarter earlier, followed by Industrials.
- Sectoral Asset Management's largest Q3 2023 buy was GoodRx Holdings: 1,007,000 shares worth $5.67M.
- Sectoral Asset Management added most to CONMED in Q3 2023, an estimated $7.87M increase.
- Sectoral Asset Management's biggest Q3 2023 reduction was Amylyx Pharmaceuticals, cutting an estimated $6.63M.
- Sectoral Asset Management fully exited Treace Medical Concepts in Q3 2023, selling an estimated $9.71M.
- Sectoral Asset Management's ten largest holdings make up 22% of its $514M portfolio in Q3 2023.
- Sectoral Asset Management opened 15 new positions and closed 13 in Q3 2023.
- Sectoral Asset Management's portfolio value fell 14% quarter-over-quarter to $514M.
Based on Sectoral Asset Management's 13F filing for Q3 2023, filed 14 Nov 2023.